Lampertico, P., Bogomolov, P. O., Chulanov, V., Stepanova, T., Morozov, V., Allweiss, L., . . . Wedemeyer, H. (2025). Phase 2 randomised study of bulevirtide as monotherapy or combined with Peg-IFNα-2a as treatment for chronic hepatitis delta. Liver international, 45(2), . https://doi.org/10.1111/liv.70008
Chicago-Zitierstil (17. Ausg.)Lampertico, Pietro, et al. "Phase 2 Randomised Study of Bulevirtide as Monotherapy or Combined with Peg-IFNα-2a as Treatment for Chronic Hepatitis Delta." Liver International 45, no. 2 (2025). https://doi.org/10.1111/liv.70008.
MLA-Zitierstil (9. Ausg.)Lampertico, Pietro, et al. "Phase 2 Randomised Study of Bulevirtide as Monotherapy or Combined with Peg-IFNα-2a as Treatment for Chronic Hepatitis Delta." Liver International, vol. 45, no. 2, 2025, https://doi.org/10.1111/liv.70008.